| NCT ID | NCT07115147 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | BPH |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-06-26 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2025-06-26 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective data collection of subjects using blude diode laser for the treatment of BPH.
Eligibility Criteria
Inclusion Criteria: * Male ≥ 50 years * Symptomatic BPH Exclusion Criteria: * Additional procedure is needed e.g. cystolithotripsy, orchidectomy etc2. Known Ca prostate patients * Patients with history of TURP * Known Urethral stricture / Bladder stone / Hypercontractile bladder * Known neurological diseases which may affect bladder function (e.g. Parkinsonism, stroke) 6. Contraindicated to undergo TURP (e.g. not fit for GA/SA, active urinary tract infection, fail to be placed in lithotomy position, uncorrectable coagulopathy, antiplatelet or anticoagulant which cannot be stopped)
Contact & Investigator
Ka Fung Peter CHIU, MBChB PhD
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT07115147 clinical trial?
This trial is open to male participants only, aged 50 Years or older, studying BPH. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07115147 currently recruiting?
Yes, NCT07115147 is actively recruiting participants. Contact the research team at peterchiu@surgery.cuhk.edu.hk for enrollment information.
Where is the NCT07115147 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07115147 clinical trial?
NCT07115147 is sponsored by Chinese University of Hong Kong. The principal investigator is Ka Fung Peter CHIU, MBChB PhD at Chinese University of Hong Kong. The trial plans to enroll 10 participants.